Michael Krel is a Partner at Sofinnova Partners in Paris, part of the Industrial Biotech team since 2013. He focuses on early-stage venture capital investments in sustainable biotechnologies across agriculture, food, chemicals, and materials. His board memberships include Microphyt, Meiogenix, ELICIT PLANT, and Werewool. Krel has held various roles within Sofinnova Partners, advancing from Senior Associate to Partner, and is also the former CEO of EnobraQ, which utilises CO2 for fermentation. He holds a PhD in Organic Chemistry from École Polytechnique and has extensive experience in business development within the biotech sector.
